Compositions and soft tissue replacement methods
US-9005605-B2 · Apr 14, 2015 · US
Methods of treating soft tissue defects
US9334262B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9334262-B2 |
| Application number | US-201414189426-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 25, 2014 |
| Priority date | Aug 19, 2010 |
| Publication date | May 10, 2016 |
| Grant date | May 10, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The specification discloses compositions and methods for treating a soft tissue defect of an individual.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating a site of a soft tissue condition of an individual in need thereof, the method comprising the steps of: administering a hydrogel material to the site of the soft tissue condition, wherein said site comprises transplanted adipose tissue; and administering a compound to the site of the soft tissue condition, wherein administration of the compound promotes formation of a blood supply sufficient to support transplanted tissue, thereby treating the soft tissue condition; wherein the hydrogel comprises a glycosaminoglycan polymer; and wherein the compound is a compound having the structure of formula V wherein each dashed line represents the presence or absence of a bond; R 4 is H, C 1-6 hydrocarbyl; o is 0, 1, 2, 3, or 4; and V is CH 3 , optionally substituted aryl or optionally substituted heteroaryl, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable amine salt thereof. 2. The method of claim 1 , wherein the compound is incorporated into a drug delivery platform comprising a biodegradable polymer matrix. 3. The method of claim 1 , wherein the hydrogel material is a porous material or solid particles. 4. The method of claim 1 , wherein glycosaminoglycan polymer is a hyaluronan polymer. 5. The method of claim 1 further comprising the step of administering adipose tissue to the site of the soft tissue condition. 6. The method of claim 1 wherein the soft tissue condition is a breast tissue condition.
Assignees
Inventors
Classifications
Tissue-regenerating or healing or proliferative agents · CPC title
Polysaccharides · CPC title
having five membered rings, e.g. pyrrolidone carboxylic acid · CPC title
for soft tissue reconstruction · CPC title
Polysaccharides · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9334262B2 cover?
- The specification discloses compositions and methods for treating a soft tissue defect of an individual.
- Who is the assignee on this patent?
- Allergan Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D409/06. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).